Header cover image
  • Investing Ideas
  • Malaysian Pharmaceuticals & Biotech Healthy potentially undervalued

Malaysian Pharmaceuticals & Biotech Healthy potentially undervalued

Results

1

0 new

Companies which are potentially undervalued and in an acceptable financial position.

1 companies

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.23

7D

1.7%

1Y

-8.9%